40
Participants
Start Date
July 31, 2010
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
PF-05186462
single intravenous infusion of 100 microgram
PF-05186462
single oral administration of 100 microgram
PF-05089771
single intravenous infusion of 100 microgram of PF-05089771
PF-05089771
single oral administration of 100 microgram PF-05089771
PF-05150122
single intravenous administration of 100 microgram PF-05150122
PF-05150122
single oral administration of 100 microgram PF-05150122
PF-05241328
single intravenous infusion of 100 microgram PF-05241328
PF-05241328
single oral administration 100 microgram PF-05241328
Pfizer Investigational Site, Edinburgh
Lead Sponsor
Pfizer
INDUSTRY